Cargando…

Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia

PURPOSE: Health utilities (HUs) are quantitative measures of quality of life that are used to derive outcomes such as quality-adjusted life years in cost-effectiveness analyses. In the Kingdom of Saudi Arabia, there are no HUs for cancer. This study aimed to generate HU estimates for various health...

Descripción completa

Detalles Bibliográficos
Autores principales: Iskedjian, Michael, De Vol, Edward, Elshenawy, Mahmoud, Bazarbashi, Shouki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605366/
https://www.ncbi.nlm.nih.gov/pubmed/33108230
http://dx.doi.org/10.1200/GO.20.00234
_version_ 1783604293402624000
author Iskedjian, Michael
De Vol, Edward
Elshenawy, Mahmoud
Bazarbashi, Shouki
author_facet Iskedjian, Michael
De Vol, Edward
Elshenawy, Mahmoud
Bazarbashi, Shouki
author_sort Iskedjian, Michael
collection PubMed
description PURPOSE: Health utilities (HUs) are quantitative measures of quality of life that are used to derive outcomes such as quality-adjusted life years in cost-effectiveness analyses. In the Kingdom of Saudi Arabia, there are no HUs for cancer. This study aimed to generate HU estimates for various health states associated with cancer in the Kingdom of Saudi Arabia. METHODS: Adult citizens of the Kingdom of Saudi Arabia, patients with cancer, and patients without cancer were recruited to participate in an online version of the Time Trade-Off (TTO) survey, a direct method that asks participants to indicate the amount of time they are willing to trade off in return for full health. The time horizon was 10 years. Patients were surveyed on their own health state; patients without cancer were presented with a scenario describing stage III colon cancer and were asked to act as proxies. RESULTS: Mean HU score was 0.398 (n = 398), 0.315 for patients with cancer (n = 199), and 0.482 for patients without cancer (n = 199). Among patients, the largest subgroup with colorectal cancer (n = 105), had a mean HU of 0.296; the subgroup with the lowest mean HU was patients with hepatocellular cancer (n = 3; 0.047), and the subgroup with the highest mean HU was patients with cholangiocarcinoma (n = 5; 0.508). Overall, the initial stage I subgroup (n = 7) had a mean HU of 0.456; initial stage II (n = 25), 0.240; stage II (n = 67), 0.319; and initial stage IV (n = 77), 0.320. CONCLUSION: To our knowledge, this is the first study of this size to elicit HU scores for cancer in the Kingdom of Saudi Arabia. Patients may have had clinically worse disease than the patients in the scenario that was presented to patients without cancer. Further analyses are warranted for specific types of cancer. These HUs can in turn be applied in cost-utility analyses.
format Online
Article
Text
id pubmed-7605366
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-76053662020-11-09 Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia Iskedjian, Michael De Vol, Edward Elshenawy, Mahmoud Bazarbashi, Shouki JCO Glob Oncol ORIGINAL REPORTS PURPOSE: Health utilities (HUs) are quantitative measures of quality of life that are used to derive outcomes such as quality-adjusted life years in cost-effectiveness analyses. In the Kingdom of Saudi Arabia, there are no HUs for cancer. This study aimed to generate HU estimates for various health states associated with cancer in the Kingdom of Saudi Arabia. METHODS: Adult citizens of the Kingdom of Saudi Arabia, patients with cancer, and patients without cancer were recruited to participate in an online version of the Time Trade-Off (TTO) survey, a direct method that asks participants to indicate the amount of time they are willing to trade off in return for full health. The time horizon was 10 years. Patients were surveyed on their own health state; patients without cancer were presented with a scenario describing stage III colon cancer and were asked to act as proxies. RESULTS: Mean HU score was 0.398 (n = 398), 0.315 for patients with cancer (n = 199), and 0.482 for patients without cancer (n = 199). Among patients, the largest subgroup with colorectal cancer (n = 105), had a mean HU of 0.296; the subgroup with the lowest mean HU was patients with hepatocellular cancer (n = 3; 0.047), and the subgroup with the highest mean HU was patients with cholangiocarcinoma (n = 5; 0.508). Overall, the initial stage I subgroup (n = 7) had a mean HU of 0.456; initial stage II (n = 25), 0.240; stage II (n = 67), 0.319; and initial stage IV (n = 77), 0.320. CONCLUSION: To our knowledge, this is the first study of this size to elicit HU scores for cancer in the Kingdom of Saudi Arabia. Patients may have had clinically worse disease than the patients in the scenario that was presented to patients without cancer. Further analyses are warranted for specific types of cancer. These HUs can in turn be applied in cost-utility analyses. American Society of Clinical Oncology 2020-10-27 /pmc/articles/PMC7605366/ /pubmed/33108230 http://dx.doi.org/10.1200/GO.20.00234 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle ORIGINAL REPORTS
Iskedjian, Michael
De Vol, Edward
Elshenawy, Mahmoud
Bazarbashi, Shouki
Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia
title Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia
title_full Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia
title_fullStr Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia
title_full_unstemmed Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia
title_short Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia
title_sort elicitation of health utilities in oncology in the kingdom of saudi arabia
topic ORIGINAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605366/
https://www.ncbi.nlm.nih.gov/pubmed/33108230
http://dx.doi.org/10.1200/GO.20.00234
work_keys_str_mv AT iskedjianmichael elicitationofhealthutilitiesinoncologyinthekingdomofsaudiarabia
AT devoledward elicitationofhealthutilitiesinoncologyinthekingdomofsaudiarabia
AT elshenawymahmoud elicitationofhealthutilitiesinoncologyinthekingdomofsaudiarabia
AT bazarbashishouki elicitationofhealthutilitiesinoncologyinthekingdomofsaudiarabia